NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3080% above fair value
$25.89−0.44 (-1.69%)
Close on Nov 17, 2026Market cap $572.56MP/E –Yield 2.01%
NRC Health total assets
Total assets on the balance sheet at the end of each period.
NRC Health's total assets was $136.15M at Jun 30, 2026. For fiscal 2025 it was $134.88M, up 1.8% from the year before. Over ten years it grew 0.5% a year on average. The highest annual figure on record is $157.54M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $134.88M | +1.8% |
| FY2024 | Dec 31, 2024 | $132.54M | +8.3% |
| FY2023 | Dec 31, 2023 | $122.44M | -6.2% |
| FY2022 | Dec 31, 2022 | $130.46M | -17.2% |
| FY2021 | Dec 31, 2021 | $157.54M | +18.1% |
| FY2020 | Dec 31, 2020 | $133.42M | +20.5% |
| FY2019 | Dec 31, 2019 | $110.69M | +2.5% |
| FY2018 | Dec 31, 2018 | $108.03M | -15.1% |
| FY2017 | Dec 31, 2017 | $127.32M | +5.5% |
| FY2016 | Dec 31, 2016 | $120.62M | -5.8% |
| FY2015 | Dec 31, 2015 | $128.05M | -1.1% |
| FY2014 | Dec 31, 2014 | $129.51M | +16.6% |
| FY2013 | Dec 31, 2013 | $111.09M | +11.0% |
| FY2012 | Dec 31, 2012 | $100.05M | -0.6% |
| FY2011 | Dec 31, 2011 | $100.68M | +5.1% |
| FY2010 | Dec 31, 2010 | $95.77M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $136.15M | -3.7% |
| Q1 FY2026 | Mar 31, 2026 | $134.56M | -0.5% |
| Q4 FY2025 | Dec 31, 2025 | $134.88M | +1.8% |
| Q3 FY2025 | Sep 30, 2025 | $135.72M | +3.0% |
| Q2 FY2025 | Jun 30, 2025 | $141.39M | +18.7% |
| Q1 FY2025 | Mar 31, 2025 | $135.18M | +11.8% |
| Q4 FY2024 | Dec 31, 2024 | $132.54M | +8.3% |
| Q3 FY2024 | Sep 30, 2024 | $131.80M | +9.7% |
| Q2 FY2024 | Jun 30, 2024 | $119.10M | -10.9% |
| Q1 FY2024 | Mar 31, 2024 | $120.91M | -10.0% |
| Q4 FY2023 | Dec 31, 2023 | $122.44M | -6.2% |
| Q3 FY2023 | Sep 30, 2023 | $120.14M | -11.0% |
| Q2 FY2023 | Jun 30, 2023 | $133.63M | -1.9% |
| Q1 FY2023 | Mar 31, 2023 | $134.31M | -12.3% |
| Q4 FY2022 | Dec 31, 2022 | $130.46M | -17.2% |
| Q3 FY2022 | Sep 30, 2022 | $134.98M | -13.6% |
| Q2 FY2022 | Jun 30, 2022 | $136.23M | -10.3% |
| Q1 FY2022 | Mar 31, 2022 | $153.15M | +4.3% |
| Q4 FY2021 | Dec 31, 2021 | $157.54M | +18.1% |
| Q3 FY2021 | Sep 30, 2021 | $156.19M | +22.7% |
| Q2 FY2021 | Jun 30, 2021 | $151.85M | +30.0% |
| Q1 FY2021 | Mar 31, 2021 | $146.88M | +26.8% |
| Q4 FY2020 | Dec 31, 2020 | $133.42M | +20.5% |
| Q3 FY2020 | Sep 30, 2020 | $127.25M | +18.2% |
| Q2 FY2020 | Jun 30, 2020 | $116.78M | +12.0% |
| Q1 FY2020 | Mar 31, 2020 | $115.86M | +10.8% |
| Q4 FY2019 | Dec 31, 2019 | $110.69M | +2.5% |
| Q3 FY2019 | Sep 30, 2019 | $107.65M | -1.0% |
| Q2 FY2019 | Jun 30, 2019 | $104.28M | +1.4% |
| Q1 FY2019 | Mar 31, 2019 | $104.57M | -20.2% |
| Q4 FY2018 | Dec 31, 2018 | $108.03M | -15.1% |
| Q3 FY2018 | Sep 30, 2018 | $108.72M | -15.6% |
| Q2 FY2018 | Jun 30, 2018 | $102.89M | -17.4% |
| Q1 FY2018 | Mar 31, 2018 | $130.98M | +3.9% |
| Q4 FY2017 | Dec 31, 2017 | $127.32M | +5.5% |
| Q3 FY2017 | Sep 30, 2017 | $128.74M | +7.9% |
| Q2 FY2017 | Jun 30, 2017 | $124.58M | – |
| Q1 FY2017 | Mar 31, 2017 | $126.06M | – |
| Q4 FY2016 | Dec 31, 2016 | $120.62M | – |
| Q3 FY2016 | Sep 30, 2016 | $119.30M | – |
See a number that looks wrong?